<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Dose Limits - ICRP-103</title>
    <style>
        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, sans-serif;
            margin: 0;
            padding: 20px;
            background: linear-gradient(135deg, #27ae60 0%, #2ecc71 100%);
            min-height: 100vh;
            color: #333;
        }
        
        .container {
            max-width: 1100px;
            margin: 0 auto;
            background: rgba(255, 255, 255, 0.95);
            border-radius: 20px;
            padding: 30px;
            backdrop-filter: blur(10px);
            box-shadow: 0 20px 40px rgba(0,0,0,0.1);
        }
        
        .header {
            text-align: center;
            margin-bottom: 40px;
            background: linear-gradient(135deg, #27ae60, #2ecc71);
            color: white;
            padding: 30px;
            border-radius: 15px;
        }
        
        .header h1 {
            margin: 0;
            font-size: 2.5em;
        }
        
        .back-nav {
            margin-bottom: 20px;
        }
        
        .back-nav a {
            display: inline-flex;
            align-items: center;
            gap: 8px;
            color: #27ae60;
            text-decoration: none;
            font-weight: 600;
            padding: 10px 20px;
            background: white;
            border-radius: 25px;
            box-shadow: 0 2px 10px rgba(0,0,0,0.1);
            transition: all 0.3s;
            margin-right: 10px;
        }
        
        .back-nav a:hover {
            transform: translateY(-2px);
            box-shadow: 0 5px 15px rgba(39, 174, 96, 0.3);
        }
        
        .dose-table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            background: white;
            border-radius: 10px;
            overflow: hidden;
            box-shadow: 0 5px 15px rgba(0,0,0,0.1);
        }
        
        .dose-table th {
            background: linear-gradient(135deg, #27ae60, #2ecc71);
            color: white;
            padding: 15px;
            text-align: center;
            font-weight: 600;
        }
        
        .dose-table td {
            padding: 12px 15px;
            text-align: center;
            border-bottom: 1px solid #dee2e6;
        }
        
        .dose-table tr:hover {
            background: #f8f9fa;
        }
        
        .category-header {
            background: #f8f9fa !important;
            color: #2c3e50 !important;
            font-weight: 700;
            text-align: left !important;
        }
        
        .effective-dose {
            background: #d4edda;
            font-weight: bold;
        }
        
        .equivalent-dose {
            background: #cce5ff;
        }
        
        .special-limit {
            background: #fff3cd;
            font-weight: bold;
        }
        
        .concept-card {
            background: white;
            border-radius: 15px;
            padding: 25px;
            margin: 20px 0;
            box-shadow: 0 5px 15px rgba(0,0,0,0.08);
            border-left: 5px solid #27ae60;
        }
        
        .concept-title {
            font-size: 1.4em;
            font-weight: 700;
            color: #2c3e50;
            margin-bottom: 15px;
            display: flex;
            align-items: center;
            gap: 10px;
        }
        
        .highlight-box {
            background: linear-gradient(135deg, #fff3cd, #ffeaa7);
            border-left: 5px solid #ffc107;
            padding: 20px;
            margin: 20px 0;
            border-radius: 10px;
        }
        
        .pregnant-box {
            background: linear-gradient(135deg, #f8d7da, #f5c6cb);
            border-left: 5px solid #dc3545;
            padding: 20px;
            margin: 20px 0;
            border-radius: 10px;
        }
        
        .key-principles {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
            gap: 15px;
            margin: 20px 0;
        }
        
        .principle-card {
            background: linear-gradient(135deg, #74b9ff, #0984e3);
            color: white;
            padding: 20px;
            border-radius: 10px;
            text-align: center;
        }
        
        .principle-title {
            font-weight: bold;
            margin-bottom: 10px;
        }
        
        .note-box {
            background: #e3f2fd;
            border-left: 4px solid #2196f3;
            padding: 15px;
            margin: 15px 0;
            border-radius: 5px;
        }
        
        .comparison-section {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 20px;
            margin: 20px 0;
        }
        
        .comparison-item {
            background: #f8f9fa;
            padding: 20px;
            border-radius: 10px;
            border-left: 4px solid #27ae60;
        }
    </style>
</head>
<body>
    <div class="container">
        <div class="back-nav">
            <a href="/reports/icrp-103.html">‚Üê Back to ICRP-103</a>
            <a href="/index.html">üè† Home</a>
        </div>
        
        <div class="header">
            <h1>‚öñÔ∏è Dose Limits</h1>
            <p>ICRP-103 Dose Limits for Occupational, Public, and Trainee Exposures</p>
        </div>
        
        <div class="concept-card">
            <div class="concept-title">üìä Dose Limits Summary Table</div>
            
            <table class="dose-table">
                <thead>
                    <tr>
                        <th>Category</th>
                        <th>Organ/Tissue</th>
                        <th>Dose Quantity</th>
                        <th>Annual Limit</th>
                        <th>5-Year Average</th>
                    </tr>
                </thead>
                <tbody>
                    <!-- Occupational Exposure -->
                    <tr class="category-header">
                        <td colspan="5"><strong>OCCUPATIONAL EXPOSURE</strong></td>
                    </tr>
                    <tr class="effective-dose">
                        <td>Workers</td>
                        <td>Whole body</td>
                        <td>Effective dose</td>
                        <td><strong>20 mSv</strong></td>
                        <td><strong>20 mSv</strong></td>
                    </tr>
                    <tr class="equivalent-dose">
                        <td>Workers</td>
                        <td>Lens of eye</td>
                        <td>Equivalent dose</td>
                        <td><strong>20 mSv</strong></td>
                        <td>-</td>
                    </tr>
                    <tr class="equivalent-dose">
                        <td>Workers</td>
                        <td>Skin</td>
                        <td>Equivalent dose</td>
                        <td><strong>500 mSv</strong></td>
                        <td>-</td>
                    </tr>
                    <tr class="equivalent-dose">
                        <td>Workers</td>
                        <td>Hands & feet</td>
                        <td>Equivalent dose</td>
                        <td><strong>500 mSv</strong></td>
                        <td>-</td>
                    </tr>
                    
                    <!-- Trainee Exposure -->
                    <tr class="category-header">
                        <td colspan="5"><strong>TRAINEE EXPOSURE (16-18 years)</strong></td>
                    </tr>
                    <tr class="effective-dose">
                        <td>Trainees</td>
                        <td>Whole body</td>
                        <td>Effective dose</td>
                        <td><strong>6 mSv</strong></td>
                        <td>-</td>
                    </tr>
                    <tr class="equivalent-dose">
                        <td>Trainees</td>
                        <td>Lens of eye</td>
                        <td>Equivalent dose</td>
                        <td><strong>20 mSv</strong></td>
                        <td>-</td>
                    </tr>
                    <tr class="equivalent-dose">
                        <td>Trainees</td>
                        <td>Skin</td>
                        <td>Equivalent dose</td>
                        <td><strong>150 mSv</strong></td>
                        <td>-</td>
                    </tr>
                    
                    <!-- Public Exposure -->
                    <tr class="category-header">
                        <td colspan="5"><strong>PUBLIC EXPOSURE</strong></td>
                    </tr>
                    <tr class="effective-dose">
                        <td>Public</td>
                        <td>Whole body</td>
                        <td>Effective dose</td>
                        <td><strong>1 mSv</strong></td>
                        <td>-</td>
                    </tr>
                    <tr class="equivalent-dose">
                        <td>Public</td>
                        <td>Lens of eye</td>
                        <td>Equivalent dose</td>
                        <td><strong>15 mSv</strong></td>
                        <td>-</td>
                    </tr>
                    <tr class="equivalent-dose">
                        <td>Public</td>
                        <td>Skin</td>
                        <td>Equivalent dose</td>
                        <td><strong>50 mSv</strong></td>
                        <td>-</td>
                    </tr>
                </tbody>
            </table>
        </div>
        
        <div class="pregnant-box">
            <h3>ü§± Special Limits for Pregnant Women</h3>
            <div class="key-principles">
                <div class="principle-card">
                    <div class="principle-title">Fetus/Embryo</div>
                    <div><strong>1 mSv</strong><br>during pregnancy</div>
                </div>
                <div class="principle-card">
                    <div class="principle-title">Monthly Limit</div>
                    <div><strong>0.5 mSv/month</strong><br>after declaration</div>
                </div>
                <div class="principle-card">
                    <div class="principle-title">Surface Dose</div>
                    <div><strong>2 mSv</strong><br>to abdominal surface</div>
                </div>
            </div>
            <div class="note-box">
                <strong>Key Point:</strong> Dose to fetus should not exceed 1 mSv during the entire pregnancy period after declaration of pregnancy.
            </div>
        </div>
        
        <div class="concept-card">
            <div class="concept-title">üîç Key Exam Points</div>
            
            <div class="highlight-box">
                <h4>üìå Most Important Values to Remember:</h4>
                <ul>
                    <li><strong>Occupational effective dose:</strong> 20 mSv/year (average over 5 years)</li>
                    <li><strong>Public effective dose:</strong> 1 mSv/year</li>
                    <li><strong>Trainee effective dose:</strong> 6 mSv/year</li>
                    <li><strong>Pregnant worker fetus:</strong> 1 mSv during pregnancy</li>
                    <li><strong>Eye lens (occupational):</strong> 20 mSv/year (changed from 150 mSv in ICRP-60)</li>
                </ul>
            </div>
            
            <div class="comparison-section">
                <div class="comparison-item">
                    <h4>ICRP-60 vs ICRP-103</h4>
                    <p><strong>Major Change:</strong></p>
                    <ul>
                        <li><strong>Eye lens limit reduced</strong></li>
                        <li>ICRP-60: 150 mSv/year</li>
                        <li>ICRP-103: 20 mSv/year</li>
                    </ul>
                </div>
                <div class="comparison-item">
                    <h4>Rationale for Reduction</h4>
                    <ul>
                        <li>New data on cataract induction</li>
                        <li>Lower threshold for cataracts</li>
                        <li>No-threshold model adopted</li>
                    </ul>
                </div>
            </div>
        </div>
        
        <div class="concept-card">
            <div class="concept-title">‚ö° Application of Dose Limits</div>
            
            <div class="note-box">
                <strong>Important Principles:</strong>
                <ul>
                    <li><strong>Effective dose limits:</strong> Apply to sum of doses from external exposure and committed effective dose from internal exposure</li>
                    <li><strong>Equivalent dose limits:</strong> Apply to individual organs/tissues</li>
                    <li><strong>5-year averaging:</strong> Allowed for occupational effective dose (max 50 mSv in any single year)</li>
                    <li><strong>ALARA principle:</strong> Doses should be as low as reasonably achievable below limits</li>
                </ul>
            </div>
            
            <div class="highlight-box">
                <h4>üéØ Dose Constraint vs Dose Limit</h4>
                <p><strong>Dose Limit:</strong> Regulatory limit that must not be exceeded</p>
                <p><strong>Dose Constraint:</strong> Upper bound of individual dose used in optimization (typically 0.1-0.3 mSv for public)</p>
            </div>
        </div>
        
        <div class="concept-card">
            <div class="concept-title">üìã Practical Implementation</div>
            
            <div class="key-principles">
                <div class="principle-card">
                    <div class="principle-title">Monitoring</div>
                    <div>Individual monitoring when dose might exceed 1 mSv/year</div>
                </div>
                <div class="principle-card">
                    <div class="principle-title">Classification</div>
                    <div>Controlled vs supervised areas</div>
                </div>
                <div class="principle-card">
                    <div class="principle-title">Investigation</div>
                    <div>Required when limits approached</div>
                </div>
            </div>
            
            <div class="note-box">
                <strong>Monitoring Threshold:</strong> Individual monitoring is required when there is reasonable possibility that effective dose will exceed 1 mSv/year or equivalent dose limits might be exceeded.
            </div>
        </div>
    </div>
</body>
</html>
